Advertiser Disclosure. Hims is an online telehealth platform for men that provides care for mental health, sexual health, hair loss, skincare and more. Outside of offering telehealth appointments ...

Hair loss treatments for men vary, from hair transplants and lasers to medications such as minoxidil and finasteride. Read on to see our picks, along with their benefits, risks, and costs.

Hims Hard Mints are a discreet alternative to ... Rex MD is an online prescription service for ED, hair loss, sleep, and other men’s health concerns and treatments. To get started, you’ll ...

Hims & Hers Health Inc (NYSE:HIMS) shares are trading higher Monday. The company is set to join to the S&P SmallCap 600 this ...

A leader in the men's health and wellness industry, Hims designed its Thick Fix Thickening Shampoo to cleanse away excess sebum to allow new follicles to grow strong and healthy. DHT-blocking saw ...

Hims & Hers Health Inc (HIMS) stock saw a modest uptick, ending the day at $17.66 which represents a slight increase of $0.53 or 3.09% from the prior close of $17.13. The stock opened at $17.55 and ...

The San Francisco telehealth company had capitalized on the shortage by making copycat versions of popular brand-name GLP-1 ...

Below is Validea's guru fundamental report for HIMS & HERS HEALTH INC (HIMS). Of the 22 guru strategies we follow, HIMS rates highest using our P/B Growth Investor model based on the published ...

Hims & Hers Health Q3 2024 revenue projected to surpass estimates by $5M-$10M. Truist consumer survey shows 10% use compounded GLP-1 medications, while 14% prefer branded options. Thursday, The ...

I make the case that investors are not paying up for any GLP1 prospects, or even, for that matter, the actual core business that Hims & Hers (NYSE:HIMS) operates in. I argue that there's a lot ...

Despite semaglutide being the active ingredient in Hims & Hers Health Inc’s (NYSE:HIMS) compounded GLP-1 product, a Truist analyst notes that the recent FDA commentary has reignited investor ...